File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Incidence rates of neurotropic-like and viscerotropic-like disease in three dengue-endemic countries: Mexico, Brazil, and Malaysia

TitleIncidence rates of neurotropic-like and viscerotropic-like disease in three dengue-endemic countries: Mexico, Brazil, and Malaysia
Authors
KeywordsDengue-endemic
Neurotropic
Tetravalent dengue vaccine
Viscerotropic
Issue Date2019
Citation
Vaccine, 2019, v. 37, n. 13, p. 1868-1875 How to Cite?
AbstractBackground: The background incidence of viscerotropic- (VLD) and neurotropic-like disease (NLD) unrelated to immunization in dengue-endemic countries is currently unknown. Methods: This retrospective population-based analysis estimated crude and standardized incidences of VLD and NLD in twelve hospitals in Brazil (n = 3), Mexico (n = 3), and Malaysia (n = 6) over a 1-year period before the introduction of the tetravalent dengue vaccine. Catchment areas were estimated using publicly available population census information and administrative data. The denominator population for incidence rates was calculated, and sensitivity analyses assessed the impact of important assumptions. Results: Total cases adjudicated as definite VLD were 5, 57, and 56 in Brazil, Mexico, and Malaysia, respectively. Total cases adjudicated as definite NLD were 103, 29, and 26 in Brazil, Mexico, and Malaysia, respectively. Crude incidence rates of cases adjudicated as definite VLD in Brazil, Mexico, and Malaysia were 1.17, 2.60, and 1.48 per 100,000 person-years, respectively. Crude incidence rates of cases adjudicated as definite NLD in Brazil, Mexico, and Malaysia were 4.45, 1.32, and 0.69 per 100,000 person-years, respectively. Conclusions: Background incidence estimates of VLD and NLD obtained in Mexico, Brazil, and Malaysia could provide context for cases occurring after the introduction of the tetravalent dengue vaccine.
Persistent Identifierhttp://hdl.handle.net/10722/311462
ISSN
2023 Impact Factor: 4.5
2023 SCImago Journal Rankings: 1.342
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorCohen, Carine-
dc.contributor.authorMoreira, Edson D.-
dc.contributor.authorNañez, Homero-
dc.contributor.authorNachiappan, Jeyaseelan P.-
dc.contributor.authorArvinder-Singh, H. S.-
dc.contributor.authorHuoi, Catherine-
dc.contributor.authorNealon, Joshua-
dc.contributor.authorSarti, Elsa-
dc.contributor.authorPuentes-Rosas, Esteban-
dc.contributor.authorMoureau, Annick-
dc.contributor.authorKhromava, Alena-
dc.date.accessioned2022-03-22T11:54:00Z-
dc.date.available2022-03-22T11:54:00Z-
dc.date.issued2019-
dc.identifier.citationVaccine, 2019, v. 37, n. 13, p. 1868-1875-
dc.identifier.issn0264-410X-
dc.identifier.urihttp://hdl.handle.net/10722/311462-
dc.description.abstractBackground: The background incidence of viscerotropic- (VLD) and neurotropic-like disease (NLD) unrelated to immunization in dengue-endemic countries is currently unknown. Methods: This retrospective population-based analysis estimated crude and standardized incidences of VLD and NLD in twelve hospitals in Brazil (n = 3), Mexico (n = 3), and Malaysia (n = 6) over a 1-year period before the introduction of the tetravalent dengue vaccine. Catchment areas were estimated using publicly available population census information and administrative data. The denominator population for incidence rates was calculated, and sensitivity analyses assessed the impact of important assumptions. Results: Total cases adjudicated as definite VLD were 5, 57, and 56 in Brazil, Mexico, and Malaysia, respectively. Total cases adjudicated as definite NLD were 103, 29, and 26 in Brazil, Mexico, and Malaysia, respectively. Crude incidence rates of cases adjudicated as definite VLD in Brazil, Mexico, and Malaysia were 1.17, 2.60, and 1.48 per 100,000 person-years, respectively. Crude incidence rates of cases adjudicated as definite NLD in Brazil, Mexico, and Malaysia were 4.45, 1.32, and 0.69 per 100,000 person-years, respectively. Conclusions: Background incidence estimates of VLD and NLD obtained in Mexico, Brazil, and Malaysia could provide context for cases occurring after the introduction of the tetravalent dengue vaccine.-
dc.languageeng-
dc.relation.ispartofVaccine-
dc.subjectDengue-endemic-
dc.subjectNeurotropic-
dc.subjectTetravalent dengue vaccine-
dc.subjectViscerotropic-
dc.titleIncidence rates of neurotropic-like and viscerotropic-like disease in three dengue-endemic countries: Mexico, Brazil, and Malaysia-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.vaccine.2019.01.087-
dc.identifier.pmid30826144-
dc.identifier.scopuseid_2-s2.0-85062079602-
dc.identifier.volume37-
dc.identifier.issue13-
dc.identifier.spage1868-
dc.identifier.epage1875-
dc.identifier.eissn1873-2518-
dc.identifier.isiWOS:000462691700019-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats